Hypothetical reasons of the HIV1-AIDS “tritherapy” failure. A challenging model-Reference-Cited by-同舟云学术

Hypothetical reasons of the HIV1-AIDS “tritherapy” failure. A challenging model

Published:1997-12 Issue:10 Volume:51 Page:413-416
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Mathé G

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference39 articles.

1. Les experts préconisent une trithérapie immédiate chez les personnes infectées par le virus du SIDA. Le comité Dormont s'interroge sur;Nau;Le Monde,1997

2. Positive effects of combined antiretroviral therapy on CD4 T cell homeostasis and function in advanced HIV disease;Autran;Science,1997

3. Treatment of human immunodeficiency virus infection with saquinavir. zidovudine and zalcitabine;Collier;N Engl J Med,1996

4. Neviparine, zidovudine and didanosine compared with zidovudine, and didanosine in patients with HIV, infection: a randomized, double-blind, placebo controlled trial;D'Aquila;Ann Intern Med,1996

5. Infections à VIH: les essais de trithérapie donnent des résultats encourageants;Jonas;Quotidien du Médecin,1996

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of haptens for the development of immunoassays for the monitoring of intracellular anti-HIV nucleosides and nucleotides;Tetrahedron;2001-09

2. Interference with complement regulatory molecules as a possible therapeutic strategy in HIV infection;Expert Opinion on Investigational Drugs;2000-02

3. Structure–activity relationship study of some inhibitors of HIV-1 integrase;Journal of Molecular Structure: THEOCHEM;1999-05

4. Combinations of four virostatics applied in rotational sequences induce an exponential VL regression curve, the first part of which is rapidly decreasing to a PCR-undetectable level, while the last part is insensitive to the model. Indications for virostatic and immunotherapeutic reinforcements?;Biomedicine & Pharmacotherapy;1999-03

5. The kinetics of cancer cells and of HIV1: the problems of cell and virus rebounds and of latency;Biomedicine & Pharmacotherapy;1998-12